Jeanne Kowalski

Title: Jeanne Kowalski: Innovator in Thyroid Tumor Research

Introduction

Jeanne Kowalski is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of medical research, particularly in the area of thyroid tumors. With a total of 2 patents, her work has the potential to impact the diagnosis and treatment of thyroid cancer.

Latest Patents

Kowalski's latest patents focus on alternative splice variant patterns of human telomerase reverse transcriptase (hTERT) in thyroid tumors. This invention provides a method for determining if a thyroid tumor in a subject is malignant. The method involves analyzing a sample from the subject to measure the amount of TERT mRNA that lacks the β sequence and the amount that comprises the β sequence. A preponderance of TERT mRNA that includes the β sequence indicates that the tumor is malignant, while a preponderance of TERT mRNA that lacks the β sequence suggests that the tumor is not malignant.

Career Highlights

Kowalski is affiliated with Johns Hopkins University, where she conducts her research. Her work has garnered attention for its innovative approach to understanding thyroid tumors and their characteristics.

Collaborations

Some of her notable coworkers include Martha Allen Zeiger and Christopher Umbricht, who contribute to the collaborative research efforts at Johns Hopkins University.

Conclusion

Jeanne Kowalski's contributions to thyroid tumor research through her patents and collaborations highlight her role as an influential inventor in the medical field. Her innovative methods have the potential to improve diagnostic accuracy and patient outcomes in thyroid cancer treatment.